RxDoctor Payments Data

Jennifer Peagler

Adult Health · West Columbia, SCNPI 1902346059

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.6% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 55 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,711, 7.5 times the $359 reported in 2021. Among adult health clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,682in general payments, 2019–2025

Across 223 payments — averaging $34.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$896
  • Merck$616
  • Incyte Corporation$599
  • Gilead$487
  • Novartis$484
  • Pfizer$407
  • plus $4K from 49 others

What the payments were for

  • Food & beverage$7,34296%
  • Education$3404%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,682 in reported general payments places this provider in the 90th percentile of 292 adult health providers in South Carolina.

See all adult health providers in South Carolina

Medicare billing

Part B allowed, 2024
$217,856
Medicare patients
476
Services billed
7,383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$20,147
XareltoRivaroxaban12$9,664
Exemestane24$2,717
Letrozole96$2,550
Anastrozole39$533
Dexamethasone14$200
Gabapentin21$176
Ondansetron OdtOndansetron11$132
Prednisone17$106
Ondansetron Hcl13$82
Pantoprazole Sodium13$75
Ciprofloxacin Hcl14$60

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$407$20,14721 claims
Johnson & JohnsonXarelto$246$9,66412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 292 adult health providers in South Carolina.

Other adult health in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →